Live feed
Filing
SC 13G
SC 13G0001144204-15-054083·Foresite Capital Fund II, L.P.
Schedule 13G ownership disclosure
Regulus Therapeutics Inc.
Security class unavailable · CUSIP: 75915K101
Event date: 2015-09-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,000,269
- Percent of class
- 3.8500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-15-054083
- Form type
- SC 13G
- Filer
- Foresite Capital Fund II, L.P.
- CIK
- CIK 1594914
- Filed
- Sep 09, 2015
- Reporting period
- Sep 02, 2015
- Description
- Schedule 13G beneficial ownership